Elevance accuses Hamaspik of poaching staff to copy its plans
Elevance Health filed a complaint on July 27, 2026, in the US District Court for the Southern District of New York against managed care organization Hamaspik, Inc. and four of its own former employees. According to the filing, Hamaspik has run a "coordinated scheme" since December 2025 to hire the people who run Elevance's New York Managed Long-Term Care (MLTC) and Fully Integrated Dual Eligible Special Needs (FIDE) plans, which combine Medicare and Medicaid coverage in a single product.
How this was made
The 30-second read
Why it matters
If the court grants injunctions or if damages are material, Elevance could face higher operating costs and competitive pressure in integrated Medicare-Medicaid offerings. Conversely, if allegations are dismissed, the impact may be reputational and limited to legal expense.
Market read
A newly reported SDNY lawsuit alleges staff poaching and trade-secret theft affecting Elevance’s New York integrated plan operations, with potential implications for injunction risk and competitive positioning.
What to watch
The market will likely focus on whether CMS star-rating performance or bonus eligibility is actually impaired, and whether any injunction restricts use of specific operational assets or templates.
Background
Elevance Health alleges Hamaspik hired former Elevance leaders running New York MLTC and FIDE plans, including claims directors and operations leadership, and allegedly took proprietary workflows and CMS star-rating related materials.
Ticker impact
Elevance Health filed a July 27 SDNY complaint alleging Hamaspik poached MLTC and FIDE staff and trade secrets, seeking injunctions and damages.
Limited immediate directional bias; watch for litigation headlines and any operational disruption tied to MLTC/FIDE plan execution.
The article is a first-report of a specific lawsuit and alleged trade-secret theft, but it provides no quantified damages, no settlement, and no stated operational loss beyond alleged competitive harm.
Market effects
Highlights heightened legal and compliance risk in managed care talent and proprietary model-of-care workflows, potentially increasing scrutiny and costs across payers.
US litigation in SDNY may drive insurer-specific headlines and risk premia for competitors in Medicare-Medicaid integrated products.
Primarily US-focused, with limited direct global market linkage unless litigation escalates to broader regulatory action.
Counterpoint
Elevance’s allegations may not translate into material losses if courts deny injunctions and the company can maintain plan performance using remaining internal staff and vendors.
Key entities
- companyElevance Health
Plaintiff in SDNY complaint alleging trade-secret misappropriation and restrictive covenant breaches tied to MLTC and FIDE plan operations.
- companyHamaspik
Defendant alleged to have hired Elevance staff and to have received or used proprietary operational materials and workflows.
- companyCenters Plan for Healthy Living
Acquired by Elevance effective December 31, 2024, per the complaint, forming part of the MLTC/FIDE operational base.